Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Laryngo- Rhino- Otologie|February 12, 2024
[Systemic therapies for advanced thyroid cancer - an update]Tim Brandenburg, Yara Maria Machlah, Dagmar Führer-SakelInnere Medizin (Heidelberg, Germany)|January 17, 2024
[Precision medicine in endocrinology exemplified by medullary thyroid cancer]Tim Brandenburg, Yara Maria Machlah, Dagmar FührerDeutsche Medizinische Wochenschrift (1946)|November 2, 2023
[Systemic therapies for advanced thyroid cancer - an update]Tim Brandenburg, Yara Maria Machlah, Dagmar Führer-SakelEuropean Journal of Endocrinology|December 23, 2025
Real-world efficacy and safety of selpercatinib in RET-mutant medullary thyroid cancer at a Tertiary Referral CenterYara Maria Machlah, Lynn Marlene Srasra, Sarah Theurer, et al.Endocrine-Related Cancer|January 16, 2026
Real-world data show limited efficacy of sequential cabozantinib treatment in RAIR-(P)DTCYara Maria Machlah, Lynn Marlene Srasra, Sarah Theurer, et al.The Journal of Clinical Endocrinology and Metabolism|May 23, 2025
Comprehensive Assessment of Multikinase Inhibitor Therapy Outcomes in RAIR-(P)DTC and MTC at a Tertiary Referral CenterYara Maria Machlah, Tim Brandenburg, Philipp Muchalla, et al.Thyroid : Official Journal of the American Thyroid Association|December 30, 2025
ALK Inhibition Prolongs Survival in a Mouse Model of <i>ALK</i>-Positive Anaplastic Thyroid CancerYara Maria Machlah, Tim Brandenburg, Georg Sebastian Hönes, et al.Pharmaceuticals (Basel, Switzerland)|September 25, 2019
Tamoxifen Protects from Vesicular Stomatitis Virus InfectionLamin B Cham, Sarah-Kim Friedrich, Tom Adomati, et al.The Journal of Clinical Endocrinology and Metabolism|April 28, 2026
Outcome Of First-Line Chemotherapy For Anaplastic Thyroid Cancer - A Multicenter Registry AnalysisKatharina Elisabeth Graf, Pia Adam, Felix Megerle, et al.Cell Reports|March 19, 2020
Dead Cells Induce Innate Anergy via Mertk after Acute Viral InfectionTom Adomati, Lamin B Cham, Thamer A Hamdan, et al.Pageof 2